Development of a durable and efficacious pre-erythrocytic malaria vaccine
Despite the licensing of RTS,S/AS01 as the first malaria vaccine by WHO, development of a durable and efficacious malaria vaccine is still needed to achieve 75% efficacy as targeted in Malaria Vaccine Technology Roadmap. While the identification of more immunogenic pre-erythrocytic malaria antigens...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2022
|
| Subjects: |